IMUGENE LIMITED — Director's Dealing 2017

Dec 10, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001. Ame	nded 01/01/11
Name of Entity:	Imugene Limited (ASX:IMU)
ACN:	009 179 551

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director:	Axel Hoos
Date of Last Notice:	2ndNovember 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

director” should be disclosed in this part.
Direct or Indirect Interest		Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change		4thDecember 2017
No. of securities held prior to change							Options 15,000,000 - 15,000,000
				Shares			Options
		Direct		7,500,000			15,000,000
		Indirect		-			-
		Total		7,500,000			15,000,000
Class		Unlisted Options:					Exercise Price 04/12/2020
			Number		Expiry		Exercise Price
			10,000,000		$0.02		04/12/2020
			10,000,000

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number acquired				Options 10,000,000 - 10,000,000
			Shares	Options
		Direct	-	10,000,000
		Indirect	-	-
		Total	-	10,000,000
Number disposed				Options - - -
			Shares	Options
		Direct	-	-
		Indirect	-	-
		Total	-	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change				Options 25,000,000 - 25,000,000
			Shares	Options
		Direct	7,500,000	25,000,000
		Indirect	-	-
		Total	7,500,000	25,000,000
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issue of Options as approved by Imugene shareholders at 2017 AGM.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

director” should be disclosed in this part.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 – +Closed period

Part 3 – +Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	N/A
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A
The CFO Solution

11 December 2017

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3